PRGO

#2148
PERRIGO COMPANY PLC
11.4000 USD
+1.37%
セクター: ヘルスケア
ベース: USD
利益通貨: USD
日中レンジ
11.3600
11.4100
1年のレンジ
9.2250
22.0100
1日の変化
+1.37%
月次変化
+20.57%
6か月変化
-47.03%
1年の変化
-47.03%
以前の終値
11.2460
始値
11.3600
Bid
Ask
安値
11.3600
High
11.4100
ボリューム
56
チャート全体を表示

Financials

概要 明細書 統計 配当金
期次 年次
  • Market Capitalization 1.5692 B
  • Employee 8 100
  • Founded N/A
  • CEO Murray S. Kessler
  • Website www.perrigo.com
  • Headquarter Ireland
  • FIGI N/A
  • Industry Technology
総売上高
当期純利益
1株当たり基本利益（基本EPS）
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-1.35
売上高対価格比率
0.45
1株当たり配当金
1.16
配当利回り（％）
8.33

Perrigo Company plc

Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters in Grand Rapids, Michigan, within Michigan State University's Grand Rapids Innovation Park. Perrigo engages in the acquisition, manufacture, and sale of consumer healthcare products, generic prescription drugs, and active pharmaceutical ingredients, primarily in the United States, from its base in Ireland. On 21 December 2018, Perrigo suffered its biggest one-day share price fall in its history after the Irish Revenue Commissioners issued a tax claim against Perrigo that equated to half of its market value.

ニュース